Autifony Therapeutics
UK - Stevenage
BiotechnologyFocus: Drugs targeting hearing disorders
Autifony Therapeutics is a life sciences company focused on Drugs targeting hearing disorders.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
AUT00201
Healthy VolunteerClinical Trials (1)
NCT04158453Safety, Blood Levels and Effects of AUT00201
Phase 1AUT00206
SchizophreniaClinical Trials (1)
NCT02589262Safety, Blood Levels and Effects of AUT00206
Phase 1Phase 1
Clinical Trials (1)
NCT05873062Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
Phase 1AUT00206
SchizophreniaClinical Trials (1)
NCT03164876Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
Phase 1Low dose AUT00206 800mg
SchizophreniaClinical Trials (1)
NCT02935725A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
Phase 1AUT00063
Tinnitus, SubjectiveClinical Trials (1)
NCT02315508Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
Phase 2AUT00063
Age-Related Hearing LossClinical Trials (1)
NCT02345031Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss
Phase 2AUT00063
Hearing LossClinical Trials (1)
NCT02832128Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2011
Portfolio: 8 clinical trials